Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Tysabri prescribing information
FDA warns about seizures linked to MS drug
Vivitrol dosing and administration
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Natural History of Multiple Sclerosis Symptoms
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Anejaculatory infertility due to multiple sclerosis.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Demyelination: the role of reactive oxygen and nitrogen species.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
In vitro modeling of central nervous system myelination and remyelination.
Pages
« first
‹ previous
…
144
145
146
147
148
149
150
151
152
…
next ›
last »